Side Effects

Some of the rodents eventually developed liver tumors, a problem seen before in mice receiving high-dose AAV gene therapy. No people have been shown to have developed liver tumors as a result of such treatments. Still, lowering the AAV dose to improve safety “is a goal,” Liu says. He and Collins are evaluating more efficient base editors to that end.